Your browser doesn't support javascript.
An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants.
Tallei, Trina Ekawati; Yelnetty, Afriza; Idroes, Rinaldi; Kusumawaty, Diah; Emran, Talha Bin; Yesiloglu, Talha Zahid; Sippl, Wolfgang; Mahmud, Shafi; Alqahtani, Taha; Alqahtani, Ali M; Asiri, Saeed; Rahmatullah, Mohammed; Jahan, Rownak; Khan, Md Arif; Celik, Ismail.
  • Tallei TE; Department of Biology, Faculty of Mathematics and Natural Sciences, Sam Ratulangi University, Manado, Indonesia.
  • Fatimawali; The University Centre of Excellence for Biotechnology and Conservation of Wallacea, Institute for Research and Community Services, Sam Ratulangi University, Manado, Indonesia.
  • Yelnetty A; The University Centre of Excellence for Biotechnology and Conservation of Wallacea, Institute for Research and Community Services, Sam Ratulangi University, Manado, Indonesia.
  • Idroes R; Pharmacy Study Program, Faculty of Mathematics and Natural Sciences, Sam Ratulangi University, Manado, Indonesia.
  • Kusumawaty D; Department of Animal Production, Faculty of Animal Husbandry, Sam Ratulangi University, Manado, Indonesia.
  • Emran TB; Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Universitas Syiah Kuala, Banda Aceh, Indonesia.
  • Yesiloglu TZ; Department of Biology, Faculty of Mathematics and Natural Sciences Education, Universitas Pendidikan Indonesia, Bandung, Indonesia.
  • Sippl W; Department of Pharmacy, BGC Trust University Bangladesh, Chittagong, Bangladesh.
  • Mahmud S; Institute of Pharmacy, Martin-Luther University of Halle-Wittenberg, Halle, Germany.
  • Alqahtani T; Institute of Pharmacy, Martin-Luther University of Halle-Wittenberg, Halle, Germany.
  • Alqahtani AM; Microbiology Laboratory, Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi, Bangladesh.
  • Asiri S; Department of Pharmacology, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.
  • Rahmatullah M; Department of Pharmacology, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.
  • Jahan R; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Najran University, Najran, Saudi Arabia.
  • Khan MA; Department of Biotechnology and Genetic Engineering, University of Development Alternative, Dhaka, Bangladesh.
  • Celik I; Department of Biotechnology and Genetic Engineering, University of Development Alternative, Dhaka, Bangladesh.
Front Pharmacol ; 12: 717757, 2021.
Article in English | MEDLINE | ID: covidwho-1399162
ABSTRACT
The rapid spread of a novel coronavirus known as SARS-CoV-2 has compelled the entire world to seek ways to weaken this virus, prevent its spread and also eliminate it. However, no drug has been approved to treat COVID-19. Furthermore, the receptor-binding domain (RBD) on this viral spike protein, as well as several other important parts of this virus, have recently undergone mutations, resulting in new virus variants. While no treatment is currently available, a naturally derived molecule with known antiviral properties could be used as a potential treatment. Bromelain is an enzyme found in the fruit and stem of pineapples. This substance has been shown to have a broad antiviral activity. In this article, we analyse the ability of bromelain to counteract various variants of the SARS-CoV-2 by targeting bromelain binding on the side of this viral interaction with human angiotensin-converting enzyme 2 (hACE2) using molecular docking and molecular dynamics simulation approaches. We have succeeded in making three-dimensional configurations of various RBD variants using protein modelling. Bromelain exhibited good binding affinity toward various variants of RBDs and binds right at the binding site between RBDs and hACE2. This result is also presented in the modelling between Bromelain, RBD, and hACE2. The molecular dynamics (MD) simulations study revealed significant stability of the bromelain and RBD proteins separately up to 100 ns with an RMSD value of 2 Å. Furthermore, despite increases in RMSD and changes in Rog values of complexes, which are likely due to some destabilized interactions between bromelain and RBD proteins, two proteins in each complex remained bonded, and the site where the two proteins bind remained unchanged. This finding indicated that bromelain could have an inhibitory effect on different SARS-CoV-2 variants, paving the way for a new SARS-CoV-2 inhibitor drug. However, more in vitro and in vivo research on this potential mechanism of action is required.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Topics: Variants Language: English Journal: Front Pharmacol Year: 2021 Document Type: Article Affiliation country: Fphar.2021.717757

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Topics: Variants Language: English Journal: Front Pharmacol Year: 2021 Document Type: Article Affiliation country: Fphar.2021.717757